2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one CAS:1044871-04-6

2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one offers multifaceted utility across a spectrum of scientific disciplines. In medicinal chemistry, it emerges as a promising lead compound for the development of innovative pharmaceuticals targeting diverse disease indications, including cancer, inflammatory disorders, and neurological conditions. The quinazolinone scaffold, renowned for its pharmacological versatility, serves as a privileged structure for the design of kinase inhibitors, receptor modulators, and enzyme inhibitors. Moreover, the presence of the pyrrolidine group confers favorable pharmacokinetic properties, such as improved metabolic stability and enhanced cellular permeability, crucial for optimizing drug-like characteristics. Researchers leverage these attributes to fine-tune the compound's activity profile and improve its efficacy in preclinical and clinical settings. Beyond drug discovery, 2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one finds application in chemical biology and molecular imaging. By conjugating fluorescent or radioactive tags to the molecule, scientists can track its interactions with biological targets, elucidate cellular mechanisms, and visualize drug distribution in living systems. This versatility positions the compound as a valuable tool for advancing our understanding of complex biological processes and accelerating the development of targeted therapeutics. In summary, 2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one emerges as a pivotal compound with transformative potential across medicinal chemistry, pharmacology, and chemical biology, offering researchers unprecedented opportunities for innovation and discovery in the pursuit of new therapeutic interventions and biological insights.